A comprehensive view of Mitsubishi Tanabe Pharma Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly Japan and Mitsubishi Tanabe Pharma release Mounjaro subcutaneous injection 2.5 mg/5 mg ATEOS in Japan administered with a once-weekly injection using an autoinjector device; drug is world's first sustained release GIP/GLP-1 receptor agonist
Published: April 21, 2023 by BioSpectrum Asia

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count